🚀 VC round data is live in beta, check it out!
MeVis Valuation Multiples
Discover revenue and EBITDA valuation multiples for MeVis and similar public comparables like PharmX Technologies, HeartBeam, Mach7 Technologies, BIT Computer and more.
MeVis Overview
About MeVis
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
Founded
1997
HQ
Employees
94
Website
Financials (FY)
EV
$45M
MeVis Financials
MeVis reported last fiscal year revenue of $19M and EBITDA of $4M.
In the same fiscal year, MeVis generated $18M in gross profit, $4M in EBITDA, and $4M in net income.
Revenue (LTM)
MeVis P&L
In the most recent fiscal year, MeVis reported revenue of $19M and EBITDA of $4M.
MeVis expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $19M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $18M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 98% | XXX | XXX | XXX |
| EBITDA | — | XXX | $4M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 15% | XXX | XXX | XXX |
| Net Profit | — | XXX | $4M | XXX | XXX | XXX |
| Net Margin | — | XXX | 20% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
MeVis Stock Performance
MeVis has current market cap of $53M, and enterprise value of $45M.
Market Cap Evolution
MeVis' stock price is $29.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45M | $53M | (0.1%) | XXX | XXX | XXX | $2.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMeVis Valuation Multiples
MeVis trades at 2.4x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
MeVis Financial Valuation Multiples
As of March 12, 2026, MeVis has market cap of $53M and EV of $45M.
Equity research analysts estimate MeVis' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
MeVis has a P/E ratio of 14.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $53M | XXX | $53M | XXX | XXX | XXX |
| EV (current) | $45M | XXX | $45M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 11.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 16.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.5x | XXX | XXX | XXX |
| P/E | — | XXX | 14.4x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 10.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MeVis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
MeVis Margins & Growth Rates
MeVis' revenue in the last fiscal year declined by (4%).
MeVis Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 21% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (24%) | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 83% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
MeVis Public Comps
See public comps and valuation multiples for other Healthcare Software and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| PharmX Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| HeartBeam | XXX | XXX | XXX | XXX | XXX | XXX |
| Mach7 Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| BIT Computer | XXX | XXX | XXX | XXX | XXX | XXX |
| SOFTMAX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MeVis M&A Activity
MeVis acquired XXX companies to date.
Last acquisition by MeVis was on XXXXXXXX, XXXXX. MeVis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by MeVis
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMeVis Investment Activity
MeVis invested in XXX companies to date.
MeVis made its latest investment on XXXXXXXX, XXXXX. MeVis invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by MeVis
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MeVis
| When was MeVis founded? | MeVis was founded in 1997. |
| Where is MeVis headquartered? | MeVis is headquartered in Germany. |
| How many employees does MeVis have? | As of today, MeVis has over 94 employees. |
| Is MeVis publicly listed? | Yes, MeVis is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of MeVis? | MeVis trades under M3V ticker. |
| When did MeVis go public? | MeVis went public in 2007. |
| Who are competitors of MeVis? | MeVis main competitors are PharmX Technologies, HeartBeam, Mach7 Technologies, BIT Computer. |
| What is the current market cap of MeVis? | MeVis' current market cap is $53M. |
| What is the current revenue of MeVis? | MeVis' last fiscal year revenue is $19M. |
| What is the current EV/Revenue multiple of MeVis? | Current revenue multiple of MeVis is 2.4x. |
| Is MeVis profitable? | No, MeVis is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.